Subscribe To
Rosen, national trial counsel, encourages farfetch limited investors with losses in excess of $100k to secure counsel before important deadline in securities class action – ftch
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchas...
November 3, 2023, 9:12 pm
America’s car-mart, inc. schedules release of second quarter fiscal year 2024 results and conference call
ROGers, Ark., Nov. 03, 2023 (GLOBE NEWSWIRE) — America’s Car-Mart, Inc. (NASDAQ: CRMT) today announ...
November 3, 2023, 9:00 pm
Vida markets expands trading horizons: mt4 and mt5 access now available
The global brokerage firm Vida Markets is offering a dual access to the MT4 and MT5 platforms. This update is a leap toward reshaping how the broker's...
November 3, 2023, 8:58 pm
Rosen, leading trial attorneys, encourages adapthealth corp. investors with losses in excess of $100k to secure counsel before important deadline in securities class action – ahco
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on...
November 3, 2023, 8:54 pm
Open society foundations announce 2023 soros justice fellows
New York, Nov. 03, 2023 (GLOBE NEWSWIRE) — The Open Society Foundations is pleased to announce the 2023 cohort of Soros Justice Fellows, which inclu...
November 3, 2023, 8:52 pm
Clearstar announces appointment of mike pritts as chief executive officer
New CEO brings a wealth of expertise to ClearStar with over 35 years of senior leadership experience in...
November 3, 2023, 8:50 pm
Global market weekly recap: oct. 30 – nov. 3, 2023
Equities and crypto were big winners this week as traders...
November 3, 2023, 8:34 pm
Cornerstone funds announce continuing monthly distributions and reset distribution amounts for 2024
NEW YORK, Nov. 03, 2023 (GLOBE NEWSWIRE) — Cornerstone Strategic Value Fund, Inc. (NYSE American: CLM...
November 3, 2023, 8:30 pm
Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance
In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-00...
November 3, 2023, 8:30 pm
Aligos therapeutics to host kol event to discuss alg-000184 phase 1, aasld late breaker data
November 16 Event to feature KOL perspective on Emerging HBV Therapies SOUTH SAN FRANCISCO, Calif., Nov...
November 3, 2023, 8:30 pm
Elicio therapeutics presents updated preliminary immunogenicity data from the ongoing phase 1 study of eli-002 and new preclinical data on eli-007 and eli-008 at the society for immunotherapy of cance
In patients with high relapse risk mKRAS-driven pancreatic and colorectal cancers who were given ELI-00...
November 3, 2023, 8:30 pm
Bdc weekly review: are bond swappers insulated from interest rate rises?
We take a look at the action in business development companies through the fourth week of October and highlight some of the key themes we are watching...
November 3, 2023, 8:19 pm
Uaw's tesla push could push musk into robotic car building faster, says ross gerber
Hosted by Brian Sullivan, “Last Call” is a fast-paced, entertaining business show that explores the inters...
November 3, 2023, 8:13 pm
Microsoft, meta, and alphabet struggle to limit ai's demand for water
Big Tech's consumption of water at its data centers is already massive, but artificial intelligence mak...
November 3, 2023, 8:08 pm
November 2023 letter to shareholders
VANCOUVER, Washington, Nov. 03, 2023 (GLOBE NEWSWIRE) — Dear Shareholders, We write to provide an upd...
November 3, 2023, 8:02 pm
Astec to present at baird’s 2023 global industrial conference
CHATTANOOGA, Tenn., Nov. 03, 2023 (GLOBE NEWSWIRE) — Astec Industries, Inc. (NASDAQ: ASTE) announced today that Jaco van der Merwe, President and Ch...
November 3, 2023, 8:01 pm
Citigroup: can jane fraser save citi?
The inability to correct underlying issues identified in multiple consent orders going back years has c...
November 3, 2023, 7:45 pm
Taysha gene therapies: tsha-102's potential is a 'buy'
Taysha Gene Therapies is a biotech stock focused on developing gene therapies for monogenic CNS diseases, with its lead candidate TSHA-102 targeting R...
November 3, 2023, 7:41 pm
Did barron's nail the peak in yields?
The old adage is that magazine covers are a jinx. That's particularly true with The Economist but Barro...
November 3, 2023, 7:35 pm
Here's what key metrics tell us about palantir technologies inc. (pltr) q3 earnings
While the top- and bottom-line numbers for Palantir Technologies Inc. (PLTR) give a sense of how the bu...
November 3, 2023, 7:33 pm